Multiple Myeloma · Cellular Therapy · Real-World Implementation

Prerna Mewawalla, MD

Prerna Mewawalla, MD
Making advanced myeloma therapy work in the real world.

Nationally recognized myeloma and cellular-therapy physician focused on sequencing CAR T-cell therapy and bispecific antibodies and bringing these treatments safely closer to patients.

Director, Stem Cell Transplant & Cellular Therapy and Apheresis Medical Director, Allegheny Health Network · Associate Professor of Medicine, Drexel University College of Medicine.

Invite Dr. Mewawalla to Speak Research & Clinical Trials Refer a Patient →
★ 2026 Castle Connolly Exceptional Woman in Medicine
Myeloma & plasma-cell specialist
Focused practice in myeloma, AL amyloidosis & MGUS
Principal investigator
Active myeloma clinical trials
National & international speaker
Invited faculty on advanced therapies
1,250+ citations ↗
Google Scholar citation count verified August 2026.
Featured in
AJMCOncLiveCancerNetworkCGTLiveTargeted OncologyOncoDaily
Dr. Prerna Mewawalla speaking on stage to a full national audience, shown on the conference screens
Invited national and international speaker in multiple myeloma and cellular therapy.
Featured Impact

Measurable change in how myeloma care is delivered.

Access

Care closer to home

Set up safe ways for patients to receive newer antibody treatments (bispecific antibodies) at local centers, so they don't always have to travel to a major hospital.

21→7

Shorter hospital stays for CAR T-cell therapy

Helped redesign how CAR T-cell therapy is given so patients spend far less time in the hospital, about 7 days instead of 21 (an internal quality-improvement result).

FACT

A fully accredited program

Helped build an accredited (FACT) stem cell transplant and cell therapy program, with clear, safe steps for every patient's care.

See the research & outcomes
Her focus

Choosing the right treatment, and giving it safely.

In the clinic and in her research, Dr. Mewawalla keeps asking the same questions: which treatment is right for each person, when to use it, and how to give it safely, including for patients who live far from a big cancer center.

Explore areas of expertise Read her story
Ways to work together

Choose your path.

Meeting Organizers & Media

Invited lectures, panels, CME, and expert commentary on multiple myeloma and cellular therapy.

Invite Dr. Mewawalla to speak

Physicians & Research Collaborators

Multi-center analyses, clinical-trial collaborations, and real-world data partnerships.

Research & clinical trials

Patients & Referring Clinicians

Referrals and appointments for myeloma, AL amyloidosis, and plasma-cell disorders through AHN.

Refer or request care